Dietary Supplementation with 20-Hydroxyecdysone Ameliorates Hepatic Steatosis and Reduces White Adipose Tissue Mass in Ovariectomized Rats Fed a High-Fat, High-Fructose Diet

Metabolic dysfunction-associated fatty liver disease (MAFLD) is defined as hepatic steatosis in combination with overweight, diabetes, or other metabolic risk factors. MAFLD affects a significant number of the global population and imposes substantial clinical and economic burdens. With no approved...

Full description

Bibliographic Details
Main Authors: Jariya Buniam, Piyachat Chansela, Jittima Weerachayaphorn, Vitoon Saengsirisuwan
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/7/2071
_version_ 1797590090002726912
author Jariya Buniam
Piyachat Chansela
Jittima Weerachayaphorn
Vitoon Saengsirisuwan
author_facet Jariya Buniam
Piyachat Chansela
Jittima Weerachayaphorn
Vitoon Saengsirisuwan
author_sort Jariya Buniam
collection DOAJ
description Metabolic dysfunction-associated fatty liver disease (MAFLD) is defined as hepatic steatosis in combination with overweight, diabetes, or other metabolic risk factors. MAFLD affects a significant number of the global population and imposes substantial clinical and economic burdens. With no approved pharmacotherapy, current treatment options are limited to diet and exercise. Therefore, the development of medicines for MAFLD treatment or prevention is necessary. 20-Hydroxyecdysone (20E) is a natural steroid found in edible plants and has been shown to improve metabolism and dyslipidemia. Therefore, it may be useful for MAFLD treatment. Here, we aimed to determine how dietary supplementation with 20E affects fat accumulation and lipogenesis in the liver and adipose tissue of ovariectomized rats fed a high-fat, high-fructose diet (OHFFD). We found that 20E reduced hepatic triglyceride content and visceral fat deposition. 20E increased the phosphorylation of AMP-activated protein kinase and acetyl CoA carboxylase while reducing the expression of fatty acid synthase in the liver and adipose tissue. Additionally, 20E increased hepatic expression of carnitine palmitoyltransferase-1 and reduced adipose expression of sterol regulatory element-binding protein-1. In conclusion, 20E demonstrated beneficial effects in rats with OHFFD-induced MAFLD. These findings suggest that 20E may represent a promising option for MAFLD prevention or treatment.
first_indexed 2024-03-11T01:15:26Z
format Article
id doaj.art-4bc56ec6828843fabb50699cb4634e70
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-11T01:15:26Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-4bc56ec6828843fabb50699cb4634e702023-11-18T18:29:04ZengMDPI AGBiomedicines2227-90592023-07-01117207110.3390/biomedicines11072071Dietary Supplementation with 20-Hydroxyecdysone Ameliorates Hepatic Steatosis and Reduces White Adipose Tissue Mass in Ovariectomized Rats Fed a High-Fat, High-Fructose DietJariya Buniam0Piyachat Chansela1Jittima Weerachayaphorn2Vitoon Saengsirisuwan3Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok 10210, ThailandDepartment of Anatomy, Phramongkutklao College of Medicine, Bangkok 10400, ThailandDepartment of Physiology, Faculty of Science, Mahidol University, Bangkok 10400, ThailandDepartment of Physiology, Faculty of Science, Mahidol University, Bangkok 10400, ThailandMetabolic dysfunction-associated fatty liver disease (MAFLD) is defined as hepatic steatosis in combination with overweight, diabetes, or other metabolic risk factors. MAFLD affects a significant number of the global population and imposes substantial clinical and economic burdens. With no approved pharmacotherapy, current treatment options are limited to diet and exercise. Therefore, the development of medicines for MAFLD treatment or prevention is necessary. 20-Hydroxyecdysone (20E) is a natural steroid found in edible plants and has been shown to improve metabolism and dyslipidemia. Therefore, it may be useful for MAFLD treatment. Here, we aimed to determine how dietary supplementation with 20E affects fat accumulation and lipogenesis in the liver and adipose tissue of ovariectomized rats fed a high-fat, high-fructose diet (OHFFD). We found that 20E reduced hepatic triglyceride content and visceral fat deposition. 20E increased the phosphorylation of AMP-activated protein kinase and acetyl CoA carboxylase while reducing the expression of fatty acid synthase in the liver and adipose tissue. Additionally, 20E increased hepatic expression of carnitine palmitoyltransferase-1 and reduced adipose expression of sterol regulatory element-binding protein-1. In conclusion, 20E demonstrated beneficial effects in rats with OHFFD-induced MAFLD. These findings suggest that 20E may represent a promising option for MAFLD prevention or treatment.https://www.mdpi.com/2227-9059/11/7/207120-hydroxyecdysonemetabolic dysfunction-associated fatty liver disease (MAFLD)ovariectomyhigh-fat high-fructose dietobesity
spellingShingle Jariya Buniam
Piyachat Chansela
Jittima Weerachayaphorn
Vitoon Saengsirisuwan
Dietary Supplementation with 20-Hydroxyecdysone Ameliorates Hepatic Steatosis and Reduces White Adipose Tissue Mass in Ovariectomized Rats Fed a High-Fat, High-Fructose Diet
Biomedicines
20-hydroxyecdysone
metabolic dysfunction-associated fatty liver disease (MAFLD)
ovariectomy
high-fat high-fructose diet
obesity
title Dietary Supplementation with 20-Hydroxyecdysone Ameliorates Hepatic Steatosis and Reduces White Adipose Tissue Mass in Ovariectomized Rats Fed a High-Fat, High-Fructose Diet
title_full Dietary Supplementation with 20-Hydroxyecdysone Ameliorates Hepatic Steatosis and Reduces White Adipose Tissue Mass in Ovariectomized Rats Fed a High-Fat, High-Fructose Diet
title_fullStr Dietary Supplementation with 20-Hydroxyecdysone Ameliorates Hepatic Steatosis and Reduces White Adipose Tissue Mass in Ovariectomized Rats Fed a High-Fat, High-Fructose Diet
title_full_unstemmed Dietary Supplementation with 20-Hydroxyecdysone Ameliorates Hepatic Steatosis and Reduces White Adipose Tissue Mass in Ovariectomized Rats Fed a High-Fat, High-Fructose Diet
title_short Dietary Supplementation with 20-Hydroxyecdysone Ameliorates Hepatic Steatosis and Reduces White Adipose Tissue Mass in Ovariectomized Rats Fed a High-Fat, High-Fructose Diet
title_sort dietary supplementation with 20 hydroxyecdysone ameliorates hepatic steatosis and reduces white adipose tissue mass in ovariectomized rats fed a high fat high fructose diet
topic 20-hydroxyecdysone
metabolic dysfunction-associated fatty liver disease (MAFLD)
ovariectomy
high-fat high-fructose diet
obesity
url https://www.mdpi.com/2227-9059/11/7/2071
work_keys_str_mv AT jariyabuniam dietarysupplementationwith20hydroxyecdysoneameliorateshepaticsteatosisandreduceswhiteadiposetissuemassinovariectomizedratsfedahighfathighfructosediet
AT piyachatchansela dietarysupplementationwith20hydroxyecdysoneameliorateshepaticsteatosisandreduceswhiteadiposetissuemassinovariectomizedratsfedahighfathighfructosediet
AT jittimaweerachayaphorn dietarysupplementationwith20hydroxyecdysoneameliorateshepaticsteatosisandreduceswhiteadiposetissuemassinovariectomizedratsfedahighfathighfructosediet
AT vitoonsaengsirisuwan dietarysupplementationwith20hydroxyecdysoneameliorateshepaticsteatosisandreduceswhiteadiposetissuemassinovariectomizedratsfedahighfathighfructosediet